From initial screening to post-transplant monitoring, reliable testing should be the standard.
From screening donors and donor organs to testing recipients pre- and post-transplantation, diagnostic tools inform decisions across a patient’s entire journey. With the right information, we enable clinicians to determine the likelihood of a successful procedure and minimize the risk of rejection of the recipient’s new graft or organ.
Roche’s comprehensive diagnostic portfolio features the right menu of highly sensitive and specific assays running on fully automated systems. This combination helps to standardize workflows and reduce testing complexity for laboratories while providing consistent and comparable results to physicians and the patients they serve.